Watertown, Mass, March 25, 2024 – Exergen’s Temporal Artery Thermometer’s including the TAT-5000S Standalone and Connected Model as well as the TAT-2000 Line including the TAT-2000C have been approved (ANVISA) for use in Brazil. The approval marks a pivotal step in ensuring that healthcare providers have access to state-of-the-art, reliable, and precise temperature monitoring tools, essential for patient care in hospitals, healthcare facilities, and elderly homes.

Revolutionizing Temperature Monitoring in Healthcare Settings
“The TAT-5000S Temporal Artery Thermometer is specifically designed for heavy-duty use in professional healthcare environments,” says Dr. Francesco Pompei, founder and CEO of Exergen Corporation. “Its approval by Brazilian health authorities underscores the country’s commitment to integrating innovative medical technologies to enhance patient care and safety”.

Key Features and Benefits

• Precision and Reliability: The TAT-5000S accuracy has been clinically proven in more than 100 peer-reviewed studies.
• Non-Invasive and Hygienic: Designed for non-intrusive use, the thermometer ensures a more comfortable experience for patients while minimizing the risk of cross-contamination.
• High productivity: Exergen Temporal Artery Thermometers take a patient’s temperature in just 2-3 seconds. As a result, doctors and nurses can check more patients’ temperatures in a shorter period of time and spend more time interacting with them.
• Durability: The Exergen TAT-5000 is engineered to withstand the rigorous demands of busy healthcare environments and is virtually unbreakable.
• Connected: The TAT-5000S Connected Model integrates with EHR systems for greater efficiency.
• Green: It is not necessary to use disposable plastic caps to clean the TAT-5000. A cotton cloth and some medicinal alcohol are sufficient for cleaning and preventing cross-contamination. Exergen has plastic caps (to cover the sensor head) and sleeves (to cover the whole thermometer) available if hospital protocol requires the use of protective consumables.

Ongoing Approvals and Importance of Regular Temperature Checks

The TAT-5000S Standalone and Connected Model are now available for professional use, Exergen also secured approval for the lite-use TAT-2000 and the TAT-2000C models, designed for at-home use. These models promise to extend the benefits of accurate and user-friendly temperature monitoring to households, further empowering individuals to take charge of their health.

Nurses, and paediatricians love Exergen’s Temporal Artery Thermometer, TAT-2000 because it is accurate, very easy to use, non-invasive, and improves productivity. It uses infrared technology to detect the heat naturally emitting from the skin surface. In addition, this method incorporates a patented arterial heat balance system to automatically account for the effects of ambient temperature on the skin. It is designed for doctors and nurses for use in hospitals and clinics.

In light of the recent dengue situation in Brazil, which has underscored the importance of vigilant health monitoring, Exergen emphasizes the critical role of regular temperature checks. The company advocates for twice-daily body temperature assessments using reliable and accurate thermometers, such as the Exergen Temporal Artery Thermometer, to enable early detection and response to potential health concerns.

About Exergen
Exergen Corporation, the leader in non-contact temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters at lower costs, with higher accuracy, less process control and higher reliability than previously possible. With its award-winning arterial thermometer, Exergen is known in both the healthcare and consumer markets. The company was founded by MIT educated and Harvard researcher Dr. Francesco Pompei, who owns more than 70 patents. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.

Media contact
Christina Guilbert
cguilbert@exergen.com

For the Health of Your Patients

Exergen P/N: 850133, Rev 1